LeadIQ logo
Learn more at LeadIQ.com

Insights

Robust Revenue Base With annual revenues ranging from one to ten billion dollars, QIAGEN presents a substantial market presence in molecular diagnostics and life sciences, offering numerous cross-selling and upselling opportunities with existing and potential clients.

Strategic Share Repurchases QIAGEN's plans to buy back up to approximately 500 million dollars in shares indicate a strong commitment to shareholder value, creating an attractive environment for investor confidence and potential client engagement through partnership or promotional initiatives.

Expanding Investor Footprint Recent significant increases in holdings by investment firms such as Orion Portfolio Solutions suggest heightened interest from institutional investors, signaling opportunities to target portfolio companies and funds investing in biotechnology.

Industry Leadership As a leading provider of sample processing and insight solutions with a global customer base exceeding 500,000 across healthcare and research sectors, QIAGEN offers ample opportunities to align sales efforts with high-volume users in molecular diagnostics and academic institutions.

Technology Integration Utilizing advanced software and automation tools like SAP BW and Articulate Storyline, QIAGEN demonstrates a focus on innovative, integrated workflows, offering potential for partners who provide complementary technological enhancements or analytics solutions that can augment their product ecosystem.

QIAGEN Tech Stack

QIAGEN uses 8 technology products and services including Adobe Creative Cloud, cdnjs, F5 BIG-IP, and more. Explore QIAGEN's tech stack below.

  • Adobe Creative Cloud
    Audio, Video, Graphics
  • cdnjs
    Content Delivery Network
  • F5 BIG-IP
    Data Security
  • SAP Business Warehouse
    Data Warehousing
  • Articulate Storyline
    Education Management
  • Lodash
    Javascript Libraries
  • AutoIt
    Programming Languages
  • SPARQL
    Programming Languages

Media & News

QIAGEN's Email Address Formats

QIAGEN uses at least 1 format(s):
QIAGEN Email FormatsExamplePercentage
First.Last@qiagen.comJohn.Doe@qiagen.com
96%
Last.F@qiagen.comDoe.J@qiagen.com
2%
Last.First@qiagen.comDoe.John@qiagen.com
1%
First.Middle@qiagen.comJohn.Michael@qiagen.com
1%

Frequently Asked Questions

What is QIAGEN's phone number?

Minus sign iconPlus sign icon You can contact QIAGEN's main corporate office by phone at
+49-7771-9****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is QIAGEN's stock symbol?

Minus sign iconPlus sign iconQIAGEN is a publicly traded company; the company's stock symbol is QGEN.

What is QIAGEN's official website and social media links?

Minus sign iconPlus sign iconQIAGEN's official website is qiagen.com and has social profiles on LinkedInCrunchbase.

How much revenue does QIAGEN generate?

Minus sign iconPlus sign icon As of December 2025, QIAGEN's annual revenue is estimated to be $5B.

What is QIAGEN's SIC code NAICS code?

Minus sign iconPlus sign iconQIAGEN's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does QIAGEN have currently?

Minus sign iconPlus sign iconAs of December 2025, QIAGEN has approximately 5.6K employees across 6 continents, including EuropeNorth AmericaAsia. Key team members include Ceo: M. C.Chief Information Security Officer: D. S.Chief Medical Officer: C. G.. Explore QIAGEN's employee directory with LeadIQ.

What industry does QIAGEN belong to?

Minus sign iconPlus sign iconQIAGEN operates in the Biotechnology Research industry.

What technology does QIAGEN use?

Minus sign iconPlus sign iconQIAGEN's tech stack includes Adobe Creative CloudcdnjsF5 BIG-IPSAP Business WarehouseArticulate StorylineLodashAutoItSPARQL.

What is QIAGEN's email format?

Minus sign iconPlus sign iconQIAGEN's email format typically follows the pattern of First.Last@qiagen.com. Find more QIAGEN email formats with LeadIQ.

How much funding has QIAGEN raised to date?

Minus sign iconPlus sign icon As of December 2025, QIAGEN has raised $750M in funding. The last funding round occurred on Aug 28, 2025 for $750M.

QIAGEN

Biotechnology ResearchLimburg, Netherlands5001-10000 Employees

QIAGEN is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life.

Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. 

QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics). 

As of December 31 2021 QIAGEN employed more than 6,000 people in over 35 locations worldwide. Further information can be found at www.qiagen.com.

Section iconCompany Overview

Phone number
+49-7771-9****
Website
qiagen.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
QGEN
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
5001-10000

Section iconMedia & News

Section iconFunding & Financials

  • $750M

    QIAGEN has raised a total of $750M of funding over 2 rounds. Their latest funding round was raised on Aug 28, 2025 in the amount of $750M.

  • $1B$10B

    QIAGEN's revenue is estimated to be in the range of $1B$10B

Section iconFunding & Financials

  • $750M

    QIAGEN has raised a total of $750M of funding over 2 rounds. Their latest funding round was raised on Aug 28, 2025 in the amount of $750M.

  • $1B$10B

    QIAGEN's revenue is estimated to be in the range of $1B$10B

Company Leadership

  • Stylized image of a person
    M. C.
    Ceo
    Phone icon
    Mobile Phone
  • Stylized image of a person
    D. S.
    Chief Information Security Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    C. G.
    Chief Medical Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. E.
    Chief Scientific Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    F. G.
    Vice President Controlling, Head Of Comops Controlling
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    B. J.
    Seo Specialist - Topic Owner
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. N.
    Senior Director Operations, Global Process Owner Plan To Produce
    Phone icon
    Mobile Phone
  • Stylized image of a person
    H. P.
    Associate Director Partner Service Business - Peak-Service
    Phone icon
    Mobile Phone
  • Stylized image of a person
    A. F.
    Assistant To The Chief Financial Officer Executive Assistant Administrative Support
    Phone icon
    Mobile Phone
  • Stylized image of a person
    C. S.
    Owner
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.